GSK (India) – World Quality Standards

GSK

Country: United Kingdom

GSK plc is a British pharmaceutical company headquartered in London. It was formed in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham. GSK shares are listed on the London Stock Exchange and are part of the FTSE 100 index, and its American depositary receipts trade in New York.

GSK's main areas are vaccines, HIV and other infectious diseases, respiratory disease and oncology. Its HIV medicines come from ViiV Healthcare, in which GSK holds 76.5%. In 2022 GSK spun off its consumer healthcare business as a separate company, Haleon.

In India GSK operates through GlaxoSmithKline Pharmaceuticals Limited, incorporated in 1924, with its head office in Mumbai, a plant in Nashik and shares listed on the NSE and BSE.

Pazopanib (Votrient) was developed at GSK and approved in 2009 for advanced kidney cancer, and later for soft tissue sarcoma. In 2015, together with GSK's oncology portfolio, the rights to the drug passed to Novartis.

Unifarm carries Votrient (pazopanib), a targeted therapy for advanced renal cell carcinoma and soft tissue sarcoma.

Official manufacturer website
GSK

List of medicines by manufacturer GSK

-5%
Votrient
View
GSK
400 mg 30 tablets
12530₴ 13180₴
✅ All products loaded (1)

Contact us

Choose a convenient way to contact

We work daily from 9:00 to 20:00